Longitudinal trends in uptake of hormonal long-acting reversible contraception devices throughout the COVID-19 pandemic: an Australian population-based study.

IF 3.4 3区 医学 Q1 FAMILY STUDIES
Tahlee Blade Stevenson, Alice R Rumbold, Vivienne Moore, Kelly Hall, Jenni Ilomaki, Danielle Mazza, Deborah Bateson, Luke E Grzeskowiak
{"title":"Longitudinal trends in uptake of hormonal long-acting reversible contraception devices throughout the COVID-19 pandemic: an Australian population-based study.","authors":"Tahlee Blade Stevenson, Alice R Rumbold, Vivienne Moore, Kelly Hall, Jenni Ilomaki, Danielle Mazza, Deborah Bateson, Luke E Grzeskowiak","doi":"10.1136/bmjsrh-2024-202224","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Little is known about the degree to which the COVID-19 pandemic, and associated restrictions and disruptions to health services, impacted the accessibility of hormonal long-acting reversible contraception (LARC) devices within Australia. Here, we explore longitudinal patterns of dispensing of the contraceptive implant and hormonal intrauterine devices (IUDs) within Australia, before and during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Population-based cohort study; analysis of 10% random sample of national Pharmaceutical Benefits Scheme dispensing data, for females aged 15-49 years dispensed a hormonal LARC device between February 2017 and November 2021.</p><p><strong>Results: </strong>Interrupted time-series analysis demonstrated overall that there were no significant differences in monthly dispensing rates of hormonal LARC following the Australian onset of the pandemic in April 2020, with no subsequent change in the trend. However, when stratified by LARC type, a significant increase was evident during the pandemic period (April 2020-November 2021) in the rate of hormonal IUD dispensing per month (0.20 per 10 000 95% CI 0.01 to 0.38)), compared with a decrease for the implant (-0.08 per 10 000 (95% CI -0.16 to 0.01)). Increases in hormonal IUD dispensing during the pandemic were most pronounced for those aged 20-24 years, new users, those without a Commonwealth concession card, and in the State of Victoria.</p><p><strong>Conclusions: </strong>Within Australia in the defined pandemic period, access to hormonal LARC devices was not negatively impacted. Rather a significant increase in dispensing of hormonal IUDs was evident.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Sexual & Reproductive Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjsrh-2024-202224","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FAMILY STUDIES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Little is known about the degree to which the COVID-19 pandemic, and associated restrictions and disruptions to health services, impacted the accessibility of hormonal long-acting reversible contraception (LARC) devices within Australia. Here, we explore longitudinal patterns of dispensing of the contraceptive implant and hormonal intrauterine devices (IUDs) within Australia, before and during the COVID-19 pandemic.

Methods: Population-based cohort study; analysis of 10% random sample of national Pharmaceutical Benefits Scheme dispensing data, for females aged 15-49 years dispensed a hormonal LARC device between February 2017 and November 2021.

Results: Interrupted time-series analysis demonstrated overall that there were no significant differences in monthly dispensing rates of hormonal LARC following the Australian onset of the pandemic in April 2020, with no subsequent change in the trend. However, when stratified by LARC type, a significant increase was evident during the pandemic period (April 2020-November 2021) in the rate of hormonal IUD dispensing per month (0.20 per 10 000 95% CI 0.01 to 0.38)), compared with a decrease for the implant (-0.08 per 10 000 (95% CI -0.16 to 0.01)). Increases in hormonal IUD dispensing during the pandemic were most pronounced for those aged 20-24 years, new users, those without a Commonwealth concession card, and in the State of Victoria.

Conclusions: Within Australia in the defined pandemic period, access to hormonal LARC devices was not negatively impacted. Rather a significant increase in dispensing of hormonal IUDs was evident.

COVID-19 大流行期间荷尔蒙长效可逆避孕药具使用率的纵向趋势:一项基于澳大利亚人口的研究。
背景:人们对 COVID-19 大流行以及相关限制和医疗服务中断在多大程度上影响了荷尔蒙长效可逆避孕药具(LARC)在澳大利亚的可及性知之甚少。在此,我们探讨了COVID-19大流行之前和期间澳大利亚国内避孕植入物和荷尔蒙宫内节育器(IUDs)的纵向发放模式:基于人群的队列研究;分析全国药品福利计划配药数据中10%的随机样本,研究对象为2017年2月至2021年11月期间获得激素LARC装置的15-49岁女性:中断时间序列分析表明,总体而言,在澳大利亚于 2020 年 4 月开始大流行后,激素类 LARC 的月配药率没有明显差异,随后的趋势也没有变化。然而,如果按 LARC 类型进行分层,在大流行期间(2020 年 4 月至 2021 年 11 月),荷尔蒙宫内节育器的月配药率明显上升(每 10 000 人 0.20(95% CI 0.01 至 0.38)),而植入式 LARC 的月配药率则下降(每 10 000 人-0.08(95% CI -0.16 至 0.01))。大流行期间,荷尔蒙宫内节育器发放量的增加在 20-24 岁人群、新使用者、没有联邦优惠卡的人群和维多利亚州最为明显:结论:在澳大利亚大流行期间,激素类 LARC 装置的使用并未受到负面影响。相反,荷尔蒙宫内节育器的配发量明显增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Sexual & Reproductive Health
BMJ Sexual & Reproductive Health Medicine-Reproductive Medicine
CiteScore
5.10
自引率
6.10%
发文量
38
期刊介绍: BMJ Sexual & Reproductive Health is a multiprofessional journal that promotes sexual and reproductive health and wellbeing, and best contraceptive practice, worldwide. It publishes research, debate and comment to inform policy and practice, and recognises the importance of professional-patient partnership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信